Pathogenesis of prostate cancer and hormone refractory prostate cancer

J S Girling, H C Whitaker, I G Mills, D E Neal

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Prostate cancer is the second most common malignancy in males and the leading cause of cancer death. Prostate cancer is initially androgen dependent and relies upon the androgen receptor (AR) to mediate the effects of androgens. The AR is also the target for therapy using antiandrogens and LHRH analogues. However, all cancers eventually become androgen independent, often referred to as hormone refractory prostate cancer. The processes involved in this transformation are yet to be fully understood but research in this area has discovered numerous potential mechanisms including AR amplification, over-expression or mutation and alterations in the AR signaling pathway. This review of the recent literature examines the current knowledge and developments in the understanding of the molecular biology of prostate cancer and hormone refractory prostate cancer, summarizing the well characterized pathways involved as well as introducing new concepts that may offer future solutions to this difficult problem.

Original languageEnglish
Pages (from-to)35-42
Number of pages8
JournalIndian journal of urology : IJU : journal of the Urological Society of India
Volume23
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Dive into the research topics of 'Pathogenesis of prostate cancer and hormone refractory prostate cancer'. Together they form a unique fingerprint.

Cite this